Received 693 new patient start forms for FILSPARI® (sparsentan) in the fourth quarter of 2024; approximately $50 million in preliminary net ...

COPENHAGEN, Denmark, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that company executives will participate in the 43rd Annual J.P. Morgan Healthcare Conference ...

Vifor Pharma, a part of Switzerland-based Galenica Group (SIX: GALN) develops pharmaceutical products for the treatment of iron deficiency. Vifor Pharma, a part of Switzerland-based Galenica Group ...

Veeda Group has unveiled a new logo and brand identity—Veeda Lifesciences—reflecting the brand’s evolution ... It offers a broad range of services to the life sciences and healthcare industries, with ...

Drugmakers plan to raise U.S. prices on at least 250 branded medications including Pfizer COVID-19 treatment Paxlovid, Bristol Myers Squibb’s cancer cell therapies, and vaccines from France’s ...

This scenario indicates that 2025 will be a promising year for the pharma sector. A report by Axis Securities last month outlined a positive outlook for the pharmaceutical sector over the next three ...

Patiromer sorbitex calcium is under clinical development by Vifor Pharma Management and currently in Phase II for Chronic Kidney Disease (Chronic Renal Failure). According to GlobalData, Phase II ...

However, China’s influence in global R&D has grown significantly, with expanding clinical trial activity and first-to-market launches. All the news that moves the needle in pharma and biotech ...

Ascentage Pharma Group International (HK:6855) has released an update. Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks Make smarter ...

Business development certainly has a role to play in companies’ innovation strategies, too, with 77% of executives surveyed noting they expect M&A to increase in 2025. AI's growing impact Beyond ...

President-elect Donald Trump exists the stage during Turning Point USA's AmericaFest at the Phoenix Convention Center on December 22, 2024, in Phoenix, Arizona. Rebecca Noble / Getty Images Some of ...